ILMN, DMED, MDR - CRWESelect.com Stock News! Illumina Inc., D. Medical Industries Ltd., McDermott International Inc. (Video Included Inside)

FOR IMMEDIATE RELEASE
Las Vegas, Nevada, United States of America (Free-Press-Release.com) January 25, 2012 -- To view video, and read the full article visit URL http://crweselect.com/28318/stock-alerts/ilmn-dmed-mdr-crweselectcom-stock-news-illumina-inc-d-medical-industries-ltd-mcdermott-international-inc-video-included-inside/

Illumina, Inc. (NASDAQ: ILMN)

According to reports, Roche Holding AG has offered to buy Illumina Incorporated - symbol ILMN - for $44.50 per share in cash, or for a total amount of about $5.7 billion

ILMN is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare.

For mnore information about ILMN please visit http://www.illumina.com

****

D. Medical Industries Ltd. (NASDAQ: DMED)

DMED announced today that its subsidiary, Spring Health Solutions Inc. ("Spring Health"), has signed a non-exclusive agreement with Solara Medical Supplies Inc. ("Solara") for distribution of its Spring(TM) Universal Infusion Sets in the United States.

DMED is a medical device company engaged through its subsidiaries in the research, development, manufacture and sale of innovative products for diabetes treatment and drug delivery. D. Medical has developed durable and semi-disposable insulin pumps, which continuously infuse insulin into a patient's body, using its proprietary spring-based delivery technology. D. Medical believes that its spring-based delivery mechanism is cost-effective compared to the motor and gear train mechanisms that drive competitive insulin pumps and also allows it to incorporate certain advantageous functions and design features in its insulin pumps. D. Medical has also developed an infusion set for insulin pumps and is focusing its research and development efforts on the development of next generation insulin pumps and a device that will combine a continuous glucose monitoring system and an insulin pump on the same patch.

For mnore information about DMED please visit http://www.dmedicalindustries.com and http://www.springnow.com

****

McDermott International, Inc. (NYSE: MDR)

MDR announced today that its Australian subsidiary has received and signed a letter of award for the Ichthys Gas-condensate Field Development subsea umbilical, riser, flowline (“SURF”) project by INPEX. The contract value is in the order of magnitude of US$2 billion and is the largest subsea contract McDermott has been awarded to date.

MDR is a leading engineering, procurement, construction and installation group of companies focused on executing complex offshore oil and gas projects worldwide. Providing fully integrated EPCI services for upstream field developments, the Company delivers fixed and floating production facilities, pipelines and subsea systems from concept to commissioning. McDermott’s customers include national and major energy companies. Operating in more than 20 countries across the Atlantic, Middle East and Asia Pacific, our integrated resources include approximately 14,000 employees and a diversified fleet of marine vessels, fabrication facilities and engineering offices. McDermott has served the energy industry since 1923.

For mnore information about MDR please visit http://www.mcdermott.com

To read the full article visit URL http://crweselect.com/28318/stock-alerts/ilmn-dmed-mdr-crweselectcom-stock-news-illumina-inc-d-medical-industries-ltd-mcdermott-international-inc-video-included-inside/

******************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWESelect.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer( http://crweselect.com/disclaimer/) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWESelect.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

ILMNcrweselect0125
DMEDcrweselect0125
MDRcrweselect0125

D. Medical Industries     DMED     Illumina     ILMN     McDermott International     MDR     Roche Holding     select